Where possibilities become realities.

TriMetis Life Sciences is a preclinical services company dedicated to helping you accelerate your research through access to specialized laboratories, quality biospecimen and research expertise.

 

 

OUR

TECHNOLOGY

OUR

SERVICES

 Ai BIOSPECIMEN QUALITY

 

Proprietary imaging technology for evaluating Quality of Slides and FFPE Blocks - % tumor, % necrosis...

 Ai DNA ISOLATION MAPPING

 

Proprietary imaging technology to assess region of interest (ROI) for selection of tumor content for NextGen Sequencing

BIOSPECIMENS

 

Leverage our global access for accurate and timely delivery.

DIGITAL IMAGE LIBRARIES

Leverage Digital Image Libraries for Ai Biomarker Development

MEDICAL DEVICE

 

Accelerate your product's unique development.

10993 CONSULTING

 

Request a risk assessment for your product.

 

ABOUT

US

TriMetis is a preclinical services company helping medical device, pharmaceutical, and biotech companies and academic institutions advance their research through specialty laboratory and consultation services.

 

In addition to our state-of-the-art GLP laboratory, TriMetis provides access to consulting services and human biospecimens to support your research.

 

Our consultants have extensive expertise in business strategy and development consulting, medical writing, protocol development, quality assurance and training, and project management services. 

 

IN THE NEWS

November 13, 2017

UTHSC, Bioworks, TriMetis join efforts

University of Tennessee Health Science Center (UTHSC) will partner with the Memphis Bioworks Foundation and TriMetis Life Sciences to focus on commercializing bioscience and technology. Dr. Steve Bares, president and executive director of Memphis Bioworks, will serve as associate vice chancellor of research and entrepreneurship at UTHSC. Phil Cestaro, vice president of Life Sciences for Bioworks and president and CEO of TriMetris, will serve as associate vice chancellor of research and business development. 

July 24, 2017

TriMetis A Case Study: Simplifying Complex Medical Sample Procurement for Tissue & Cancer Research

The market for procuring biospecimens for medical research is very complex and has a number of moving parts. In this case study by Streamline, they focus on how TriMetis’s Biospecimen division, which specializes in acquiring and delivering biospecimens for research, uses Streamline to aid researchers with more accurate and timely biospecimen delivery.

December 01, 2014

TriMetis' biospecimen's help define a key role for TIGIT in inhibiting chronic CD8 + T cell-dependent responses

TriMetis worked with Genentech on a prospective study to deliver Human Tumor and PBMC Samples Matched whole blood and fresh surgically resected tumor tissues. This study was successful in helping push Genentech's research forward

Please reload

  • LinkedIn Social Icon
  • Instagram Social Icon
  • Facebook Social Icon
  • Twitter Social Icon

CONTACT

US

OUR

ADDRESSES

CORPORATE HEADQUARTERS:

20 South Dudley Street, Suite 806 

Memphis, TN

38103

Email: info@TriMetisLifeSciences.com
Tel:  +1 (901) 866 1818

Contact Us:

Memphis, TN: +1 (901) 410-1441

  +1 (617) 714-9805

Fax: +1 (617) 714-9807

Email: info@trimetislifesciences.com